Page 2 - Insulin Value Program News Today

Last Tuesday, Novo Nordisk, made an announcement that it too would be cutting the U.S. list price of its insulin products, including NOVOLOG insulin...

On March 1, Eli Lilly was the first to announce U.S. list price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps...

The product is not expected on store shelves until at least next year.

Starting next month, some Medicare beneficiaries will pay less out of pocket for 27 prescription drugs whose prices rose faster than inflation late last year.

Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S. list prices of several insulin products by up to 75% for people living with Type 1 and type 2 diabetes. It becomes the second drugmaker to do so, following Eli Lilly's announcement earlier this month that it was capping out-of-pocket costs to $35 a month for insulin. Novo Nordisk products include

The high cost of insulin, which is relatively cheap to manufacture, has been in the spotlight for many years.

Novo Nordisk said Tuesday it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce

CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.

In the fourth quarter of 2023, Eli Lilly and Co will cut list prices by 70 percent for its most commonly prescribed insulin products, Humalog and Humulin

In the fourth quarter of 2023, Eli Lilly and Co will cut list prices by 70 percent for its most commonly prescribed insulin products, Humalog and Humulin